NASDAQ:LNSR

LENSAR (LNSR) Stock Price, News & Analysis

$3.25
+0.02 (+0.62%)
(As of 04/22/2024 ET)
Today's Range
$3.15
$3.31
50-Day Range
$3.02
$5.00
52-Week Range
$1.80
$5.30
Volume
19,344 shs
Average Volume
40,668 shs
Market Capitalization
$37.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

LENSAR MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
146.2% Upside
$8.00 Price Target
Short Interest
Healthy
0.83% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

Medical Sector

517th out of 910 stocks

Surgical & Medical Instruments Industry

58th out of 95 stocks

LNSR stock logo

About LENSAR Stock (NASDAQ:LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LNSR Stock Price History

LNSR Stock News Headlines

LENSAR Inc Ordinary Shares LNSR
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Analysts’ Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
LENSAR Q4 2023 Earnings Preview
Navigating 6 Analyst Ratings For Viridian Therapeutics
LENSAR Stock (NASDAQ:LNSR), Short Interest Report
LENSAR Decline Means Insider Profits Down To US$42k
LENSAR's Earnings Outlook
Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?
See More Headlines
Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/04/2024
Today
4/23/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LNSR
Fax
N/A
Employees
130
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+146.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,380,000.00
Pretax Margin
-34.11%

Debt

Sales & Book Value

Annual Sales
$42.16 million
Book Value
$2.97 per share

Miscellaneous

Free Float
3,874,000
Market Cap
$37.03 million
Optionable
Optionable
Beta
0.47
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

LNSR Stock Analysis - Frequently Asked Questions

Should I buy or sell LENSAR stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LNSR shares.
View LNSR analyst ratings
or view top-rated stocks.

What is LENSAR's stock price target for 2024?

1 equities research analysts have issued 1-year price objectives for LENSAR's stock. Their LNSR share price targets range from $8.00 to $8.00. On average, they predict the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 146.2% from the stock's current price.
View analysts price targets for LNSR
or view top-rated stocks among Wall Street analysts.

How have LNSR shares performed in 2024?

LENSAR's stock was trading at $3.51 at the start of the year. Since then, LNSR stock has decreased by 7.4% and is now trading at $3.25.
View the best growth stocks for 2024 here
.

Are investors shorting LENSAR?

LENSAR saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 77,300 shares, an increase of 85.8% from the March 15th total of 41,600 shares. Based on an average daily trading volume, of 43,700 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.8% of the shares of the stock are short sold.
View LENSAR's Short Interest
.

When is LENSAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our LNSR earnings forecast
.

How were LENSAR's earnings last quarter?

LENSAR, Inc. (NASDAQ:LNSR) announced its quarterly earnings results on Monday, March, 4th. The company reported ($0.22) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.22). The firm earned $12.11 million during the quarter. LENSAR had a negative trailing twelve-month return on equity of 40.53% and a negative net margin of 34.11%.

How do I buy shares of LENSAR?

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LNSR) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners